Lexaria Bioscience Corp. (LEXX)
0.6601
-0.03
(-4.18%)
USD |
NASDAQ |
Apr 30, 11:36
Lexaria Bioscience Total Assets (Quarterly) : 6.487M for Feb. 28, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 7.582M |
| Aurinia Pharmaceuticals, Inc. | 770.59M |
| Edesa Biotech, Inc. | 14.71M |
| Xenon Pharmaceuticals, Inc. | 981.67M |
| ProMIS Neurosciences, Inc. | 9.182M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.277M |
| Shareholders Equity (Quarterly) | 6.602M |
| Debt to Equity Ratio | 0.0143 |
| Current Ratio | 26.88 |
| Net Debt Paydown Yield | 0.04% |